General MedicationsORALStandard
SYPRINE
TRIENTINE HYDROCHLORIDE
Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview SYPRINE is listed in Drugs@FDA under application 019194 (NDA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient TRIENTINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 250MG Sponsor BAUSCH Submission history Latest submission status date: 2015-03-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview SYPRINE is listed in Drugs@FDA under application 019194 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient TRIENTINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 250MG Sponsor BAUSCH Submission history Latest submission status date: 2015-03-03 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.